Literature DB >> 16001258

Engineering Bacillus subtilis ATCC 6633 for improved production of the lantibiotic subtilin.

Stefan Heinzmann1, Karl-Dieter Entian, Torsten Stein.   

Abstract

To improve the production of the lantibiotic subtilin in Bacillus subtilis ATCC 6633, two genetic engineering strategies were followed. Firstly, additional copies of subtilin self-protection (immunity) genes spaIFEG have been integrated into the genome of the producer strain. Their expression significantly enhanced the subtilin tolerance level, and concomitantly, the subtilin yield 1.7-fold. Secondly, a repressor of subtilin gene expression, the B. subtilis general transition state regulator protein AbrB, was deleted. A sixfold enhancement of the subtilin yield could be achieved with the abrB deletion mutant; however, the produced subtilin fraction predominantly consists of succinylated subtilin species with less antimicrobial activity compared to unmodified subtilin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001258     DOI: 10.1007/s00253-005-0023-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  17 in total

1.  Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361.

Authors:  Gaoyan Wang; David C Manns; John J Churey; Randy W Worobo
Journal:  Appl Environ Microbiol       Date:  2014-06       Impact factor: 4.792

2.  Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

Authors:  Paul D Cotter; Lorraine A Draper; Elaine M Lawton; Olivia McAuliffe; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Validation of the intact zwittermicin A biosynthetic gene cluster and discovery of a complementary resistance mechanism in Bacillus thuringiensis.

Authors:  Yi Luo; Li-Fang Ruan; Chang-Ming Zhao; Cheng-Xian Wang; Dong-Hai Peng; Ming Sun
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

4.  Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties.

Authors:  B VidyaLaxme; A Rovetto; R Grau; Renu Agrawal
Journal:  J Food Sci Technol       Date:  2012-09-19       Impact factor: 2.701

5.  Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with high antimicrobial activity.

Authors:  Sebastian W Fuchs; Thorsten W Jaskolla; Sophie Bochmann; Peter Kötter; Thomas Wichelhaus; Michael Karas; Torsten Stein; Karl-Dieter Entian
Journal:  Appl Environ Microbiol       Date:  2011-01-14       Impact factor: 4.792

6.  Synthesis and succinylation of subtilin-like lantibiotics are strongly influenced by glucose and transition state regulator AbrB.

Authors:  Sophie M Bochmann; Tobias Spieß; Peter Kötter; Karl-Dieter Entian
Journal:  Appl Environ Microbiol       Date:  2014-11-07       Impact factor: 4.792

7.  The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.

Authors:  Bingyue Xin; Jinshui Zheng; Ziya Xu; Xiaoling Song; Lifang Ruan; Donghai Peng; Ming Sun
Journal:  Appl Environ Microbiol       Date:  2014-12-29       Impact factor: 4.792

8.  The Lcn972 bacteriocin-encoding plasmid pBL1 impairs cellobiose metabolism in Lactococcus lactis.

Authors:  Ana B Campelo; Paula Gaspar; Clara Roces; Ana Rodríguez; Jan Kok; Oscar P Kuipers; Ana Rute Neves; Beatriz Martínez
Journal:  Appl Environ Microbiol       Date:  2011-09-02       Impact factor: 4.792

9.  Influence of growth conditions on the nisin production of bioengineered Lactococcus lactis strains.

Authors:  O Simşek; A H Con; N Akkoç; P E J Saris; Mustafa Akçelik
Journal:  J Ind Microbiol Biotechnol       Date:  2009-01-10       Impact factor: 3.346

10.  Continuous nisin production with bioengineered Lactococcus lactis strains.

Authors:  O Simşek; N Akkoç; A H Con; F Ozçelik; P E J Saris; Mustafa Akçelik
Journal:  J Ind Microbiol Biotechnol       Date:  2009-04-01       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.